| Pharmaceutical active ingredients: |
| Octinoxate |
| Available forms, composition and doses of Visible Lift SPF 17: |
| Cream; Topical; Octinoxate 4% |
| Visible Lift SPF 17 medical category: |
| Human:DermatologicalsSunburn protectantsSunscreen agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D02BA02 - Octinoxate |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| L'Oreal |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Visebad | Vitamin A; Vitamin B1; Vitamin B2; Vitamin B3 (Nicotinamide); Vitamin B5 (D-Panthenol); Vitamin B6; Vitamin C; Vitamin D | Otto Pharmaceutical Industries |
| Visergil | Ergoloid Mesylates; Thioridazine; Thioridazine Hydrochloride | Novartis; LPB Istituto Farmaceutico |
| Viserul | Ranitidine | Unidentified Pharmaceutical Company |
| Vises | Valdecoxib | Sysmed Laboratories |
| Visial | Hyaluronate Sodium | Cadila; Zydus Cadila |
| Visible Results SPF 15 | Octinoxate; Titanium Dioxide | L'Oreal |
| Vi-Siblin | Psyllium | Pfizer |
| Vi-Siblin S | Psyllium; Sorbitol | Pfizer |
| Visicol | Sodium Phosphate Dibasic Anhydrous; Sodium Phosphate Monobasic Monohydrate | Salix Pharmaceuticals; InKine Pharmaceutical Company; Pharmaceutical Manufacturing Research Services |
| Visidex II | Test for Glucose in Blood | Bayer Schering Pharma |